GlucoTrack, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, net loss was USD 4.69 million compared to USD 3.15 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4553 USD | -1.02% | -44.48% | +74.11% |
Apr. 22 | GlucoTrack, Inc. announced that it has received $0.5 million in funding | CI |
Apr. 16 | Glucotrack Expanding Glucose Monitoring Technology to Epidural Space | MT |
1st Jan change | Capi. | |
---|---|---|
+74.11% | 12.18M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |